Experiment 825377
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | GOLD,EJ: BOSL,GJ: ITRI,LM:. (1984). PHASE II TRIAL OF 13-CIS-RETINOIC ACID IN PATIENTS WITH ADVANCED NONSEMINOMATOUS GERM CELL TUMORS.. 68(10) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II TRIAL OF 17 PATIENTS WITH ADVANCED NONSEMINOMATOUS GERM CELL TUMORS WERE TREATED DAILY.OF 15 PATIENTS WITH EVALUABLE RESPONSE,THERE WAS NO OBJECTIVE RESPONSE,ALTHOUGH 4 PATIENTS HAD STABLE DISEASE. HYPERKERATOSIS AND/OR CHEILOSIS AFFECTED 13 OF 15 PATIENTS.OTHER TOXIC EFFECTS INCLUDE ARTHRALGIA,MUCOSITIS,CONJUNCTIVITIS,AND MULTIPLE PARONYCHIAE.NO MYELOSUPPRESSION WAS OBSERVED. |
| Dose amount | 100.0 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | KG |
| Dose expression | DOSE |